Industry & Policy News

[Nature News] Many publishers, including Elsevier and Springer Nature, have said that authors can use ChatGPT and other large language model (LLM) tools to help them produce their manuscripts, as long as they declare it.

[University of Missouri] Dr. Andrew Kelleher, assistant professor in the Department of Obstetrics, Gynecology and Women’s Health at the University of Missouri School of Medicine has been awarded a five-year, $2.17 million grant from the Eunice Kennedy Shriver National Institute of Child Health and Human Development to study the ability of cells in a women’s uterine endometrial lining to regenerate in a manner similar to stem cells.

[ScienceInsider] When Svetlana Mojsov heard the spring 2021 announcement, she was startled. The Canada Gairdner International Award, a prestigious biomedical research prize, would be bestowed on three scientists for work underpinning the diabetes and obesity drugs that have exploded in popularity in recent years. “I was really upset,” recalls Mojsov, a chemist at Rockefeller University.

[Max-Planck-Gesellschaft] The Max Planck-Humboldt Medal will be awarded to Kandice Tanner from the Center for Cancer research, NCI NIH, for developing methods of analyzing the biophysical properties and behavior that dictate the metastatic spread of cancer cells.

[Geovax Labs, Inc.] GeoVax Labs, Inc. announced that it has met the enrollment target for its Phase II clinical trial evaluating GEO-CM04S1 as a booster for healthy patients who have previously received the Pfizer or Moderna mRNA vaccine

[Ohio State University] The Ohio State University Wexner Medical Center is one of the first nationwide to administer a targeted gene therapy for patients with a specific form of amyotrophic lateral sclerosis, a neurodegenerative disease that affects the cells in the brain and spine.